HCA Healthcare (HCA) Projected to Release Earnings on Friday

Posted by Stanley Muller on Jul 23rd, 2026

HCA Healthcare (NYSE:HCA – Get Free Report) will likely be releasing its Q2 2026 results before the market opens on Friday, July 24th. Analysts expect HCA Healthcare to post earnings of $7.56 per share and revenue of $19.7568 billion for the quarter. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Parties can find conference call details on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Friday, July 24, 2026 at 10:00 AM ET.

HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the previous year, the business posted $6.45 EPS. On average, analysts expect HCA Healthcare to post $29 EPS for the current fiscal year and $33 EPS for the next fiscal year.

HCA Healthcare Stock Down 0.1%

HCA Healthcare stock opened at $372.58 on Thursday. The company’s 50 day moving average is $388.88 and its two-hundred day moving average is $454.89. The firm has a market cap of $82.65 billion, a PE ratio of 12.81, a price-to-earnings-growth ratio of 1.26 and a beta of 1.12. HCA Healthcare has a 52-week low of $330.00 and a 52-week high of $556.52.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s payout ratio is presently 10.73%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on HCA. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Leerink Partners reduced their target price on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Wells Fargo & Company set a $369.00 price objective on shares of HCA Healthcare in a research report on Monday. Cantor Fitzgerald decreased their price objective on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research report on Tuesday, July 7th. Finally, Argus decreased their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $483.45.

View Our Latest Analysis on HCA

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

Negative Sentiment: Multiple plaintiff law firms have launched investigations into HCA Healthcare over possible securities-law violations, increasing headline risk and investor uncertainty. HCA Healthcare, Inc. Investigated by the Portnoy Law Firm
Negative Sentiment: Bragar Eagel & Squire is also investigating HCA on behalf of stockholders, adding to the cluster of legal inquiries that could pressure the shares. HCA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating HCA Healthcare, Inc.
Negative Sentiment: Pomerantz LLP has opened a similar investigation, reinforcing concerns that the stock could face further legal scrutiny. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA
Negative Sentiment: Kessler Topaz Meltzer & Check is likewise investigating HCA for potential federal securities-law violations, adding to the negative legal backdrop. NYSE: HCA Investigation: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. Investors to Contact the Firm
Neutral Sentiment: HCA Florida Lake Monroe Hospital welcomed 29 new resident physicians, a routine operational update that is unlikely to move the stock on its own. HCA Florida Lake Monroe Hospital welcomes 29 new resident physicians
Neutral Sentiment: HCA also highlighted leadership and project updates at several facilities, including promotions and new CMO appointments, which are more operational than market-moving. HCA Florida promotes CEO of 2 hospitals Arabinda Pani joins HCA Houston Healthcare Kingwood as CMO Think big: HCA rep. updates Rotary on Long Pt. ER and other projects
Negative Sentiment: An HCA Georgia hospital paused most services amid flooding, which could create near-term operational disruption and reputational concerns. HCA Georgia hospital pauses most services amid flooding
Neutral Sentiment: A story on HCA’s enterprise AI strategy was largely informational and highlights longer-term efficiency efforts rather than an immediate earnings catalyst. How HCA Healthcare built its enterprise AI strategy

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Palisade Asset Management LLC acquired a new stake in shares of HCA Healthcare during the third quarter worth about $26,000. JPL Wealth Management LLC purchased a new stake in HCA Healthcare during the 3rd quarter valued at approximately $33,000. Greenline Wealth Management LLC purchased a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $42,000. EFG International AG purchased a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $44,000. Finally, Triumph Capital Management purchased a new position in HCA Healthcare in the 3rd quarter valued at $51,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

(Get Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.